| 000 | 01675 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515184532.0 | ||
| 264 | 0 | _c20100119 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1421-9832 | ||
| 024 | 7 |
_a10.1159/000235974 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRen, Xiaoxiao | |
| 245 | 0 | 0 |
_aRecombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model. _h[electronic resource] |
| 260 |
_bDermatology (Basel, Switzerland) _c2009 |
||
| 300 |
_a232-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEar _xpathology |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aInjections |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
| 650 | 0 | 4 |
_aInterleukin-4 _xadministration & dosage |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xpathology |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 700 | 1 | _aLi, Jiong | |
| 700 | 1 | _aZhou, Xikun | |
| 700 | 1 | _aLuo, Xiaolei | |
| 700 | 1 | _aHuang, Nongyu | |
| 700 | 1 | _aWang, Yongsheng | |
| 700 | 1 | _aChen, Xiancheng | |
| 700 | 1 | _aWei, Yuquan | |
| 773 | 0 |
_tDermatology (Basel, Switzerland) _gvol. 219 _gno. 3 _gp. 232-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000235974 _zAvailable from publisher's website |
| 999 |
_c19130173 _d19130173 |
||